262 related articles for article (PubMed ID: 26639242)
1. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free Urinary MicroRNAs Expression in Small-Scale Experiments.
Zavesky L; Jandakova E; Turyna R; Duskova D; Langmeierova L; Weinberger V; Minar L; Horinek A; Kohoutova M
Methods Mol Biol; 2017; 1580():99-106. PubMed ID: 28439829
[TBL] [Abstract][Full Text] [Related]
4. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.
Chen T; Wang C; Yu H; Ding M; Zhang C; Lu X; Zhang CY; Zhang C
EBioMedicine; 2019 Jan; 39():552-561. PubMed ID: 30467011
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
7. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
8. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162
[TBL] [Abstract][Full Text] [Related]
9. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
[TBL] [Abstract][Full Text] [Related]
10. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
[TBL] [Abstract][Full Text] [Related]
11. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
12. New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L; Kohoutova M
Neoplasma; 2015; 62(4):509-20. PubMed ID: 25997972
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
14. Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus.
Perez-Hernandez J; Forner MJ; Pinto C; Chaves FJ; Cortes R; Redon J
PLoS One; 2015; 10(9):e0138618. PubMed ID: 26390437
[TBL] [Abstract][Full Text] [Related]
15. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease.
Eissa S; Matboli M; Aboushahba R; Bekhet MM; Soliman Y
J Diabetes Complications; 2016; 30(8):1585-1592. PubMed ID: 27475263
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
Logan M; Hawkins SM
Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
[TBL] [Abstract][Full Text] [Related]
17. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients.
Srivastava A; Moxley K; Ruskin R; Dhanasekaran DN; Zhao YD; Ramesh R
AAPS J; 2018 Jul; 20(5):82. PubMed ID: 29987691
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
